AMGN: the medicine cabinet for your portfolioOn the weekly chart, Amgen (AMGN) trades at $289.56, holding above the key $272–280 support zone, aligned with the 0.705–0.79 Fibo levels. This area forms a clear buy zone, where buyers are likely to step in. The technical structure remains bullish: the uptrend is intact, with targets at $346.85, ma
Key facts today
Amgen Inc. will invest over $600 million in a new Center for Science & Innovation in Thousand Oaks, California, starting construction this quarter and creating hundreds of jobs.
0.35 USD
3.63 B USD
29.52 B USD
About Amgen Inc.
Sector
Industry
CEO
Robert A. Bradway
Website
Headquarters
Thousand Oaks
Founded
1980
ISIN
ARDEUT110665
FIGI
BBG000HDW649
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Related stocks
Utilizing algorithms to identify A+ trade opportunitiesMy typical video consists of analyzing a specific chart and telling its story. But here, I take a different approach and analyze how to actually capitalize on the knowledge we have through the algorithms.
As you'll see, these are repeated algorithms that we've identified from previous price actio
AMGN Long Trade Setup!📈
🕒 Timeframe: 30 min
🔻 Pattern: Falling wedge nearing breakout 🔼
📍 Entry Zone: ~$277.00 ✅
🎯 Target: $283.35 💰
🛑 Stop Loss: Below $274.00 ⚠️
🔥 Why It Looks Bullish:
🔺 Falling wedge structure — a known bullish pattern
🧱 Strong bounce off demand zone (support + yellow line)
💚 Green reversal candle
Amgen - V-shaped bottom at uptrend supportNASDAQ:AMGN is looking at a potential run up and given the positive momentum, the AMGN may break 289.97 resistance. The stock has broken above the overhead resistance and is likely to reach our 1st resistance at 309.57.
Furthermore, stochastic oscillator is showing oversold crossover and 23-perio
Pioneering Human Therapeutics $AMGNAmgen, Inc. is a biotechnology company that specializes in the discovery, development, manufacture, and marketing of human therapeutics. Founded on April 8, 1980, by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld, the company is headquartered in Thousa
Long? Yes I Am-genNothing revolutionary here today, just an algo call on a stock that has been a solid performer for me historically.
The rationale:
--In a trading range longer term, but a short/medium term uptrend
--right at short term support level
--1313-1* W/L record with my algo (the 1 being 2 days ago and stil
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
AMGN5235280
Amgen Inc. 3.0% 15-JAN-2052Yield to maturity
—
Maturity date
Jan 15, 2052
AMGN.GV
Amgen Inc. 6.4% 01-FEB-2039Yield to maturity
—
Maturity date
Feb 1, 2039
AMGN4436563
Amgen Inc. 4.663% 15-JUN-2051Yield to maturity
—
Maturity date
Jun 15, 2051
AMGN5235279
Amgen Inc. 1.65% 15-AUG-2028Yield to maturity
—
Maturity date
Aug 15, 2028
AMGN.HG
Amgen Inc. 5.15% 15-NOV-2041Yield to maturity
—
Maturity date
Nov 15, 2041
AMGN.GR
Amgen Inc. 6.375% 01-JUN-2037Yield to maturity
—
Maturity date
Jun 1, 2037
AMGN.GU
Amgen Inc. 6.9% 01-JUN-2038Yield to maturity
—
Maturity date
Jun 1, 2038
AMGN4368348
Amgen Inc. 4.663% 15-JUN-2051Yield to maturity
—
Maturity date
Jun 15, 2051
AMGN5235281
Amgen Inc. 2.0% 15-JAN-2032Yield to maturity
—
Maturity date
Jan 15, 2032
AMGN.GY
Amgen Inc. 5.75% 15-MAR-2040Yield to maturity
—
Maturity date
Mar 15, 2040
AMGN4368346
Amgen Inc. 4.563% 15-JUN-2048Yield to maturity
—
Maturity date
Jun 15, 2048
See all AMGND bonds
Curated watchlists where AMGND is featured.